albendazole has been researched along with methylcellulose in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iseki, K; Kohri, N; Miyazaki, K; Sato, N; Todo, S; Xin, H; Yamayoshi, Y | 1 |
| Chu, SW; Ehteda, A; Galettis, P; Morris, DL; Pillai, K | 1 |
2 other study(ies) available for albendazole and methylcellulose
| Article | Year |
|---|---|
Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique.
Topics: Administration, Oral; Albendazole; Animals; Anticestodal Agents; Biological Availability; Drug Carriers; Hydrogen-Ion Concentration; Hypromellose Derivatives; Intestinal Absorption; Male; Methylcellulose; Rabbits; Time Factors; X-Ray Diffraction | 1999 |
Complexation of albendazole with hydroxypropyl-β-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Acetic Acid; Albendazole; Animals; beta-Cyclodextrins; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Female; HCT116 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hypromellose Derivatives; Injections, Intraperitoneal; Methylcellulose; Mice; Mice, Nude; Solutions; Suspensions; Tubulin Modulators; Xenograft Model Antitumor Assays | 2012 |